Colinz Laboratories Limited (COLINZ.BO)
INR 55.65
(5.0%)
INR 55.65
(5.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 14.64 Million INR | -18.11% |
| 2022 | 5.03 Million INR | 30.83% |
| 2021 | 3.85 Million INR | 173.78% |
| 2020 | 1.4 Million INR | 30.28% |
| 2019 | 1.07 Million INR | -19.92% |
| 2018 | 1.34 Million INR | -2.01% |
| 2017 | 1.37 Million INR | -4.67% |
| 2016 | 1.44 Million INR | -14.74% |
| 2015 | 1.69 Million INR | -36.62% |
| 2014 | 2.67 Million INR | 26.79% |
| 2013 | 2.1 Million INR | -41.82% |
| 2012 | 3.62 Million INR | 30.62% |
| 2011 | 2.77 Million INR | 21.57% |
| 2010 | 2.27 Million INR | -0.14% |
| 2009 | 2.28 Million INR | -24.03% |
| 2008 | 3 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.26 Million INR | 37.27% |
| 2024 Q2 | 1.42 Million INR | 12.15% |
| 2023 Q2 | 940 Thousand INR | -20.0% |
| 2023 Q3 | 1.08 Million INR | 15.64% |
| 2023 FY | 4.12 Million INR | -18.11% |
| 2023 Q1 | 1.17 Million INR | -8.27% |
| 2023 Q4 | 923 Thousand INR | -15.09% |
| 2022 Q1 | 1.13 Million INR | 72.58% |
| 2022 Q3 | 1.03 Million INR | -23.24% |
| 2022 Q4 | 1.28 Million INR | 23.89% |
| 2022 FY | 5.03 Million INR | 30.83% |
| 2022 Q2 | 1.34 Million INR | 18.26% |
| 2021 FY | 3.85 Million INR | 173.78% |
| 2021 Q1 | 907 Thousand INR | 5.49% |
| 2021 Q2 | 1.26 Million INR | 39.14% |
| 2021 Q3 | 1.02 Million INR | -19.1% |
| 2021 Q4 | 660 Thousand INR | -35.36% |
| 2020 Q2 | 961 Thousand INR | 7.61% |
| 2020 Q1 | 893 Thousand INR | 395.11% |
| 2020 Q3 | 625 Thousand INR | -34.96% |
| 2020 Q4 | 859.76 Thousand INR | 37.56% |
| 2020 FY | 1.4 Million INR | 30.28% |
| 2019 Q1 | 933 Thousand INR | 89.5% |
| 2019 FY | 1.07 Million INR | -19.92% |
| 2019 Q4 | 180.36 Thousand INR | -73.55% |
| 2019 Q3 | 682 Thousand INR | 7.57% |
| 2019 Q2 | 634 Thousand INR | -32.05% |
| 2018 FY | 1.34 Million INR | -2.01% |
| 2018 Q4 | 492.35 Thousand INR | -4.77% |
| 2018 Q3 | 517 Thousand INR | -39.67% |
| 2018 Q2 | 857 Thousand INR | 28.87% |
| 2018 Q1 | 665 Thousand INR | 6.57% |
| 2017 FY | 1.37 Million INR | -4.67% |
| 2017 Q3 | 822 Thousand INR | 4.05% |
| 2017 Q2 | 790 Thousand INR | 624.77% |
| 2017 Q4 | 624 Thousand INR | -24.09% |
| 2017 Q1 | 109 Thousand INR | -82.16% |
| 2016 Q2 | 1.08 Million INR | 66.87% |
| 2016 Q1 | 649 Thousand INR | 4.51% |
| 2016 Q4 | 611 Thousand INR | 20.28% |
| 2016 Q3 | 508 Thousand INR | -53.09% |
| 2016 FY | 1.44 Million INR | -14.74% |
| 2015 Q4 | 621 Thousand INR | 11.09% |
| 2015 Q2 | 637 Thousand INR | -25.5% |
| 2015 Q3 | 559 Thousand INR | -12.24% |
| 2015 FY | 1.69 Million INR | -36.62% |
| 2015 Q1 | 855 Thousand INR | 68.64% |
| 2014 Q2 | 627 Thousand INR | -13.4% |
| 2014 Q1 | 724 Thousand INR | 73.62% |
| 2014 Q4 | 507 Thousand INR | -32.22% |
| 2014 FY | 2.67 Million INR | 26.79% |
| 2014 Q3 | 748 Thousand INR | 19.3% |
| 2013 Q2 | 410 Thousand INR | -42.09% |
| 2013 Q4 | 417 Thousand INR | -26.84% |
| 2013 FY | 2.1 Million INR | -41.82% |
| 2013 Q1 | 708 Thousand INR | -25.97% |
| 2013 Q3 | 570 Thousand INR | 39.02% |
| 2012 Q4 | 956.36 Thousand INR | 53.76% |
| 2012 Q2 | 1.01 Million INR | -0.39% |
| 2012 FY | 3.62 Million INR | 30.62% |
| 2012 Q1 | 1.02 Million INR | 58.46% |
| 2012 Q3 | 622 Thousand INR | -38.96% |
| 2011 Q3 | 722 Thousand INR | 0.0% |
| 2011 Q4 | 645.57 Thousand INR | -10.58% |
| 2011 FY | 2.77 Million INR | 21.57% |
| 2010 FY | 2.27 Million INR | -0.14% |
| 2009 Q4 | 520 Thousand INR | 0.0% |
| 2009 FY | 2.28 Million INR | -24.03% |
| 2008 FY | 3 Million INR | 0.0% |
| 2008 Q4 | 967 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| ANG Lifesciences India Limited | 12.8 Million INR | -14.354% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 81.123% |
| Bacil Pharma Limited | -1.89 Million INR | 872.987% |
| BDH Industries Limited | 169.01 Million INR | 91.336% |
| Beryl Drugs Limited | 14.73 Million INR | 0.604% |
| Cian Healthcare Limited | 53.96 Million INR | 72.868% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 10.904% |
| Concord Drugs Limited | 24.87 Million INR | 41.127% |
| Deccan Health Care Limited | 185.32 Million INR | 92.099% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 72.752% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -62.881% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 98.285% |
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -2653.479% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 97.811% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -83.773% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 97.076% |
| Panchsheel Organics Limited | 288.28 Million INR | 94.921% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 138.782% |
| Parnax Lab Limited | 166.84 Million INR | 91.224% |
| Makers Laboratories Limited | -34.91 Million INR | 141.945% |
| Medi-Caps Limited | -17.21 Million INR | 185.084% |
| MedPlus Health Services Limited | 1.31 Billion INR | 98.89% |
| Phaarmasia Limited | - INR | -Infinity% |
| Parmax Pharma Limited | 3.75 Million INR | -290.007% |
| Patidar Buildcon Limited | -1.83 Million INR | 897.549% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 77.287% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 3706.65% |
| Trident Lifeline Limited | 72.21 Million INR | 79.722% |
| Tyche Industries Limited | 111.22 Million INR | 86.835% |
| Vivanza Biosciences Limited | 14.83 Million INR | 1.274% |
| PRAVEG LIMITED | 185.06 Million INR | 92.088% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 57.128% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 93.211% |
| Sastasundar Ventures Limited | -229.64 Million INR | 106.376% |
| Transchem Limited | -17.43 Million INR | 183.967% |
| Trinity League India Limited | 1.17 Million INR | -1148.338% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 95.686% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 244.309% |
| Sunil Healthcare Limited | -19.98 Million INR | 173.285% |
| Syschem (India) Limited | 504.91 Million INR | 97.1% |
| Zenith Healthcare Limited | 196 Thousand INR | -7370.918% |
| Zenlabs Ethica Limited | 89.27 Million INR | 83.598% |
| Mercury Laboratories Limited | 62.14 Million INR | 76.439% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 85.16% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 76.103% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 109.148% |
| Roopa Industries Limited | 48.05 Million INR | 69.53% |
| PANJON LTD. | - INR | -Infinity% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 109.807% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 181.727% |
| Anuh Pharma Limited | 682.19 Million INR | 97.854% |
| Crestchem Limited | 27.25 Million INR | 46.276% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 224.568% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 14.493% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 95.98% |
| Trimurthi Limited | -6.14 Million INR | 338.367% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 93.802% |
| Norris Medicines Limited | 11.15 Million INR | -31.243% |
| Veerhealth Care Limited | 34.19 Million INR | 57.174% |
| Lactose (India) Limited | 137.78 Million INR | 89.373% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 111.85% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 96.648% |
| Gennex Laboratories Limited | 146.61 Million INR | 90.013% |
| Denis Chem Lab Limited | 142.87 Million INR | 89.751% |
| Godavari Drugs Limited | -67.67 Million INR | 121.639% |
| Zenotech Laboratories Limited | 242.37 Million INR | 93.959% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 97.442% |
| Bharat Parenterals Limited | 733.49 Million INR | 98.004% |
| Coral Laboratories Limited | 142.63 Million INR | 89.734% |
| Evoq Remedies Limited | 42.91 Million INR | 65.881% |
| Kerala Ayurveda Limited | 48.04 Million INR | 69.523% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 690.444% |
| Natural Capsules Limited | 112.4 Million INR | 86.972% |
| Auro Laboratories Limited | 95.77 Million INR | 84.711% |